Article

Development of a novel oral treatment that rescues gait ataxia and retinal degeneration in…

medRxiv · 2022 · Elisabetta Morini

Key facts

Title Development of a novel oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia.
First author Elisabetta Morini
Journal medRxiv
Published Nov 4, 2022
DOI 10.1101/2022.11.04.515198
Devices mentioned BK110039, K103302, K171498, K933267
Product codes mentioned DCN, LJM, NDS, PCA, KIP, KIT, MVU, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature